- Tools
- Downloads
- Links
- Community
- About
- Help
FB2026_01
,
released March 12, 2026
[97C3-97C3];[97D11-97D11];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
97C3;97D11
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Df(3R)nm136/Df(3R)BSC524 does not result in embryonic VNC defects or embryonic lethality.
Inferred to overlap with: Df(3R)nm136.
Exelixis, Inc. determined the insertion site of P{XP}d05561 to be Release 3 genomic coordinate 22773773 on chromosome arm 3R. This corresponds to 97D11 on the Release 3 and Release 5 genome maps. The predicted position of PBac{WH}f06726 on the Release 5 map is 97C3. Consequently, the cytological breakpoints of Df(3R)BSC524 are predicted to be 97C3;97D11.